business
CorMedix Inc. (CRMD) Reports Q1 2026 Results
Key takeaways
- (CRMD) Reports Q1 2026 Results Fatima Gulzar Sun, June 14, 2026 at 1:07 AM GMT+7 1 min read CRMD Cor Medix Inc.
- 10 Most Profitable Small Cap Stocks to Buy.
- (NASDAQ:CRMD) reported Q1 net revenue of $127.4 million and net income of $38.6 million with adjusted EBITDA of $70.0 million.
Cor Medix Inc. (CRMD) Reports Q1 2026 Results Fatima Gulzar Sun, June 14, 2026 at 1:07 AM GMT+7 1 min read CRMD Cor Medix Inc. (NASDAQ:CRMD) is one of the
10 Most Profitable Small Cap Stocks to Buy.
On May 14, 2026, Cor Medix Inc. (NASDAQ:CRMD) reported Q1 net revenue of $127.4 million and net income of $38.6 million with adjusted EBITDA of $70.0 million. The firm said Defen Cath contributed $97.5 million in revenue with higher outpatient dialysis utilization and a $9.0 million favorable estimate change. The acquired Melinta portfolio added $29.9 million.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop